XML 63 R46.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of the components of income tax expense
The following table outlines the components of the Company’s income tax expense for the periods presented:
 For the Year Ended December 31,
 202420232022
 (in thousands)
Current income tax expense:   
Federal$49,676 $50,911 $47,825 
State and local14,135 13,262 13,467 
Total current income tax expense63,811 64,173 61,292 
Deferred income tax expense (benefit)(4,315)(6,286)(8,639)
Total income tax expense$59,496 $57,887 $52,653 
Schedule of reconciliations of the statutory federal income tax rate to the effective income tax rate
Reconciliations of the federal statutory income tax rate to the effective income tax rate are as follows:
 For the Year Ended December 31,
 202420232022
Federal income tax at statutory rate21.0 %21.0 %21.0 %
State and local income taxes, less federal income tax benefit4.6 4.2 4.4 
Permanent differences0.7 0.3 0.2 
Deferred income taxes — state income tax rate adjustment— (0.3)(0.4)
Revision to prior years’ estimated taxes
0.3 0.4 (0.4)
Stock-based compensation(0.0)(0.5)(0.5)
Non-controlling interest(0.6)(0.5)(0.6)
Other(0.3)(0.7)(0.5)
Effective income tax rate25.7 %23.9 %23.2 %
Schedule of deferred tax assets and liabilities
The Company’s deferred tax assets and liabilities are as follows:
December 31,
 20242023
 (in thousands)
Deferred tax assets  
Implicit discounts and adjustments$10,970 $11,685 
Compensation and benefit-related accruals21,017 17,217 
Professional malpractice liability insurance6,872 7,838 
Federal and state net operating loss and state tax credit carryforwards3,602 3,288 
Interest limitation carryforward2,153 — 
Stock awards142 151 
Operating lease liabilities123,301 106,329 
Research and experimental expenditures9,048 7,929 
Other3,206 2,707 
Deferred tax assets180,311 157,144 
Valuation allowance(2,618)(2,933)
Deferred tax assets, net of valuation allowance$177,693 $154,211 
Deferred tax liabilities  
Depreciation and amortization$(80,947)$(76,776)
Operating lease right-of-use assets(113,491)(98,055)
Other(4,223)(2,744)
Deferred tax liabilities(198,661)(177,575)
Deferred tax liabilities, net of deferred tax assets$(20,968)$(23,364)
The Company’s deferred tax assets and liabilities are included in the consolidated balance sheet captions as follows:
December 31,
 20242023
 (in thousands)
Other assets$4,412 $— 
Non-current deferred tax liability(25,380)(23,364)
$(20,968)$(23,364)
Schedule of state net operating loss carryforwards
State net operating loss carryforwards expire and are subject to valuation allowances as follows:
State Net Operating LossesGross Valuation Allowance
 (in thousands)
2025$1,124 $1,124 
20261,253 1,253 
2027829 829 
2028220 220 
Thereafter through 2043
47,749 41,771 
Total
$51,175 $45,197